bufalin has been researched along with Cardiac Toxicity in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-Aty, AM; Ashrafizadeh, M; Cheng, Y; Fan, Y; Fang, S; Gong, P; Hacimuftuoglu, A; Hu, M; Li, W; Linnebacher, M; Shi, D; Yuan, J; Zhang, J; Zhang, W; Zhang, X | 1 |
| Li, H; Li, M; Ma, J; Wang, JX; Wang, XJ; Xing, HY; Zhang, XX; Zhang, YZ; Zhao, Q; Zhi, YY | 1 |
| Chen, M; Chen, P; Shi, F; Tang, L; Wang, Y; Xu, Y; Zheng, M | 1 |
3 other study(ies) available for bufalin and Cardiac Toxicity
| Article | Year |
|---|---|
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Cell Membrane; Drug Resistance, Multiple; Mice; Pancreatic Neoplasms | 2023 |
Bufalin-induced cardiotoxicity: new findings into mechanisms.
Topics: Bufanolides; Cardiotoxicity; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Ion Channels; Myocytes, Cardiac | 2020 |
Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.
Topics: Animals; Antineoplastic Agents; Bufanolides; Cardiotoxicity; Cell Death; Drug Carriers; Hemolysis; Hep G2 Cells; Humans; Nanoparticles; Neoplasms; Particle Size; Polymers; Serum Albumin, Bovine | 2021 |